-
1
-
-
12844254318
-
Cdx2 as a marker for neuroendocrine neoplasms of unknown primary sites
-
Erickson LA, Papouchado B, Dimashkieh H, et al. Cdx2 as a marker for neuroendocrine neoplasms of unknown primary sites. Endocr Pathol. 2004;15:247-252.
-
(2004)
Endocr Pathol
, vol.15
, pp. 247-252
-
-
Erickson, L.A.1
Papouchado, B.2
Dimashkieh, H.3
-
2
-
-
14644411795
-
Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids
-
Saqi A, Alexis D, Remotti F, et al. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol. 2005;123:394-404.
-
(2005)
Am J Clin Pathol
, vol.123
, pp. 394-404
-
-
Saqi, A.1
Alexis, D.2
Remotti, F.3
-
3
-
-
0037441624
-
5-decade analysis of 13,715 carcinoid neoplasms
-
Modlin IM, Lye KD, Kidd MA. 5-decade analysis of 13,715 carcinoid neoplasms. Cancer. 2003;97:934-959.
-
(2003)
Cancer
, vol.97
, pp. 934-959
-
-
Modlin, I.M.1
Lye, K.D.2
Kidd, M.A.3
-
4
-
-
1842339356
-
An analysis of 8305 cases of carcinoid neoplasms
-
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid neoplasms. Cancer. 1997;79:813-829.
-
(1997)
Cancer
, vol.79
, pp. 813-829
-
-
Modlin, I.M.1
Sandor, A.2
-
5
-
-
79952308016
-
Future directions in the treatment of neuroendocrine neoplasms: Consensus report of the National Cancer Institute Neuroendocrine Neoplasm clinical trials planning meeting
-
Kulke MH, Siu LL, Tepper JE, et al. Future directions in the treatment of neuroendocrine neoplasms: consensus report of the National Cancer Institute Neuroendocrine Neoplasm clinical trials planning meeting. J Clin Oncol. 2011;29: 934-943.
-
(2011)
J Clin Oncol
, vol.29
, pp. 934-943
-
-
Kulke, M.H.1
Siu, L.L.2
Tepper, J.E.3
-
6
-
-
4344644561
-
CDX-2 homeobox gene product expression in neuroendocrine neoplasms: Its role as a marker of intestinal neuroendocrine neoplasms
-
Barbareschi M, Roldo C, Zamboni G, et al. CDX-2 homeobox gene product expression in neuroendocrine neoplasms: its role as a marker of intestinal neuroendocrine neoplasms. Am J Surg Pathol. 2004;28:1169-1176.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 1169-1176
-
-
Barbareschi, M.1
Roldo, C.2
Zamboni, G.3
-
7
-
-
3142568489
-
TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location
-
Du EZ, Goldstraw P, Zacharias J, et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol. 2004;35:825-831.
-
(2004)
Hum Pathol
, vol.35
, pp. 825-831
-
-
Du, E.Z.1
Goldstraw, P.2
Zacharias, J.3
-
8
-
-
70349678291
-
KIT is an independent prognostic marker for pancreatic endocrine neoplasms: A finding derived from analysis of islet cell differentiation markers
-
Zhang L, Smyrk TC, Oliveira AM, et al. KIT is an independent prognostic marker for pancreatic endocrine neoplasms: a finding derived from analysis of islet cell differentiation markers. Am J Surg Pathol. 2009;33:1562-1569.
-
(2009)
Am J Surg Pathol
, vol.33
, pp. 1562-1569
-
-
Zhang, L.1
Smyrk, T.C.2
Oliveira, A.M.3
-
9
-
-
40849114945
-
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine neoplasms and their metastases
-
Schmitt AM, Riniker F, Anlauf M, et al. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine neoplasms and their metastases. Am J Surg Pathol. 2008;32:420-425.
-
(2008)
Am J Surg Pathol
, vol.32
, pp. 420-425
-
-
Schmitt, A.M.1
Riniker, F.2
Anlauf, M.3
-
10
-
-
84862786905
-
Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine neoplasms of pancreatic origin
-
Koo J, Mertens RB, Mirocha JM, et al. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine neoplasms of pancreatic origin. Mod Pathol. 2012;25:893-902.
-
(2012)
Mod Pathol
, vol.25
, pp. 893-902
-
-
Koo, J.1
Mertens, R.B.2
Mirocha, J.M.3
-
11
-
-
0348047628
-
Gene regulatory factors in pancreatic development
-
Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn. 2004;229:176-200.
-
(2004)
Dev Dyn
, vol.229
, pp. 176-200
-
-
Jensen, J.1
-
12
-
-
0031020002
-
Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells
-
Ahlgren U, Pfaff SL, Jessell TM, et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature. 1997;385:257-260.
-
(1997)
Nature
, vol.385
, pp. 257-260
-
-
Ahlgren, U.1
Pfaff, S.L.2
Jessell, T.M.3
-
13
-
-
0025280050
-
Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo-and a Cys-His domain
-
Karlsson O, Thor S, Norberg T, et al. Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo-and a Cys-His domain. Nature. 1990;344: 879-882.
-
(1990)
Nature
, vol.344
, pp. 879-882
-
-
Karlsson, O.1
Thor, S.2
Norberg, T.3
-
14
-
-
0025794399
-
Islet cell and extrapancreatic expression of the LIM domain homeobox gene isl-1
-
Dong J, Asa SL, Drucker DJ. Islet cell and extrapancreatic expression of the LIM domain homeobox gene isl-1. Mol Endocrinol. 1991;5:1633-1641.
-
(1991)
Mol Endocrinol
, vol.5
, pp. 1633-1641
-
-
Dong, J.1
Asa, S.L.2
Drucker, D.J.3
-
15
-
-
0036290271
-
Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice
-
Mutoh H, Hakamata Y, Sato K, et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 2002;294:470-479.
-
(2002)
Biochem Biophys Res Commun
, vol.294
, pp. 470-479
-
-
Mutoh, H.1
Hakamata, Y.2
Sato, K.3
-
16
-
-
0036180974
-
Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice
-
Silberg DG, Sullivan J, Kang E, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 2002;122:689-696.
-
(2002)
Gastroenterology
, vol.122
, pp. 689-696
-
-
Silberg, D.G.1
Sullivan, J.2
Kang, E.3
-
17
-
-
8144224902
-
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas
-
Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004;17: 1392-1399.
-
(2004)
Mod Pathol
, vol.17
, pp. 1392-1399
-
-
Kaimaktchiev, V.1
Terracciano, L.2
Tornillo, L.3
-
18
-
-
12344329808
-
Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian neoplasms from metastatic colorectal carcinoma
-
Logani S, Oliva E, Arnell PM, et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian neoplasms from metastatic colorectal carcinoma. Mod Pathol. 2005;18:19-25.
-
(2005)
Mod Pathol
, vol.18
, pp. 19-25
-
-
Logani, S.1
Oliva, E.2
Arnell, P.M.3
-
19
-
-
66549088325
-
CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma
-
Erratum in: Appl Immunohistochem Mol Morphol. 2009;17(5) 464
-
Saad RS, Silverman JF, Khalifa MA, et al. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma. Appl Immunohistochem Mol Morphol. 2009;17:196-201. Erratum in: Appl Immunohistochem Mol Morphol. 2009;17(5):464.
-
(2009)
Appl Immunohistochem Mol Morphol
, vol.17
, pp. 196-201
-
-
Saad, R.S.1
Silverman, J.F.2
Khalifa, M.A.3
-
20
-
-
77951820987
-
PAX8 Expression in welldifferentiated pancreatic endocrine neoplasms: Correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid neoplasms
-
Long KB, Srivastava A, Hirsch MS, et al. PAX8 Expression in welldifferentiated pancreatic endocrine neoplasms: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid neoplasms. Am J Surg Pathol. 2010;34: 723-729.
-
(2010)
Am J Surg Pathol
, vol.34
, pp. 723-729
-
-
Long, K.B.1
Srivastava, A.2
Hirsch, M.S.3
-
21
-
-
79952187699
-
PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine neoplasms from ileal and pulmonary well-differentiated neuroendocrine neoplasms and pancreatic acinar cell carcinoma
-
Sangoi AR, Ohgami RS, Pai RK, et al. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine neoplasms from ileal and pulmonary well-differentiated neuroendocrine neoplasms and pancreatic acinar cell carcinoma. Mod Pathol. 2011;24:412-424.
-
(2011)
Mod Pathol
, vol.24
, pp. 412-424
-
-
Sangoi, A.R.1
Ohgami, R.S.2
Pai, R.K.3
-
22
-
-
84855500753
-
Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine neoplasms
-
Lorenzo PI, Jimenez Moreno CM, Delgado I, et al. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine neoplasms. Histochem Cell Biol. 2011;136:595-607.
-
(2011)
Histochem Cell Biol
, vol.136
, pp. 595-607
-
-
Lorenzo, P.I.1
Jimenez Moreno, C.M.2
Delgado, I.3
-
23
-
-
0034763904
-
Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine neoplasms
-
Cai YC, Banner B, Glickman J, et al. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine neoplasms. Hum Pathol. 2001;32:1087-1093.
-
(2001)
Hum Pathol
, vol.32
, pp. 1087-1093
-
-
Cai, Y.C.1
Banner, B.2
Glickman, J.3
-
24
-
-
0032936648
-
Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine neoplasms
-
Folpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine neoplasms. Mod Pathol. 1999;12:5-8.
-
(1999)
Mod Pathol
, vol.12
, pp. 5-8
-
-
Folpe, A.L.1
Gown, A.M.2
Lamps, L.W.3
|